Research outputs

Since 2016 we've attracted almost £6m in active research funding (York Against Cancer, MRC, BBSRC, CRUK, Breast Cancer Now, Kidney Research UK, Bowel Research UK, the Wellcome Trust and industrial partnerships).

We publish in leading general and discipline-specific journals (EMBO Molecular Medicine, Journal of Clinical Investigation, Nature Communications, Genome Research, Human Molecular Genetics, Oncogene, Breast Cancer Research, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology and the British Journal of Cancer). 

Research in the Jack Birch Unit has led to clinical trials (eg Sodium 23Na-MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer, NaRNIA). We hold and curate UroBank, the world’s only urinary tract focused tissue bank. We also produce evidence that impacts on treatment guidelines for viral infections in kidney transplant recipients who are at a higher risk of bladder cancers.

Research impact

The vision of the Jack Birch Unit is to harness preclinical fundamental research into epithelial tumours to deliver real world clinical impact, through:

• high-impact publications
• development of biomarkers and targets
• patient and public Involvement (PPI)
• policy making and clinical guidance
• engagement with industry
• Training the next generation of cancer researchers

Recent publications 

Follow the below links to take a look at our publications in the York Research Database.

• Professor Will Brackenbury
• Dr Simon Baker
• Dr Vicki Jennings
• Professor Dimitris Lagos
• Dr Andrew Mason